Related Experiment Video
Updated: Jul 4, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Carriership of Factor V Leiden and evolutionary selection advantage
Pelle G Lindqvist1, Björn Dahlbäck
1Clinical Sciences, Malmö, Obstetrics and Gynecology, Sweden. Pelle.lindqvist@med.lu.se
Abstract:
Historically, lethal exsanguinations and severe infections have been two major causes of maternal death. Gene mutations that lower the risk of profuse hemorrhage or severe infections would give a survival advantage. A single mutation of coagulation factor V, known as FV Leiden (FVL), can be such a beneficial mutation. FVL is common among Caucasians and today confers an increased risk of thromboembolism. However, the high prevalence of FVL (up to 15%) in the general population suggests that it has given an evolutionary advantage. In this review, we discuss possible mechanisms of the evolutionary survival advantage associated with FVL. In women, FVL confers lower risk of blood loss and profuse hemorrhage in association with delivery and improves the hemoglobin status. In addition, FVL carriers possibly have a survival advantage during sepsis. In conclusion, the high prevalence of FVL may be the result of one or more evolutionary selection advantages.
Related Concept Videos
Frequency-dependent Selection
Pleiotropy
Carrier Generation and Recombination
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...
Viral Mutations
Evolution of New Traits in Microbes
Mutation, Gene Flow, and Genetic Drift

